Sue Robb
Impact in
-
- Heart Failure Treatment and Management
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Heart Failure Treatment and Management 3
- Cardiac pacing and defibrillation studies 1
- Atrial Fibrillation Management and Outcomes 1
- Chemotherapy-induced cardiotoxicity and mitigation 1
- Cardiovascular Function and Risk Factors 1
- Surgery 1
- Hemodynamic Monitoring and Therapy 1
- Co-authors
- John J.V. McMurray (3 shared papers)David Murdoch (2 shared papers)Anna Jones (1 shared paper)Andrew Wardley (1 shared paper)Peter Barrett‐Lee (1 shared paper)Theresa A. McDonagh (3 shared papers)Mark Verrill (1 shared paper)Peter Canney (1 shared paper)
- Journals
- Journal of the American College of Cardiology (1 paper)British Journal of Cancer (1 paper)Heart (1 paper)European Heart Journal (1 paper)The Journal of Heart and Lung Transplantation (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Sue Robb
6 papers receiving 288 citations
Peers
Comparison fields: 5 of 57
- Cardiology and Cardiovascular Medicine 259
- Oncology 116
- Family Practice 4
- Radiology, Nuclear Medicine and Imaging 41
- Cancer Research 18
Countries citing papers authored by Sue Robb
This map shows the geographic impact of Sue Robb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Robb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Robb more than expected).
Fields of papers citing papers by Sue Robb
This network shows the impact of papers produced by Sue Robb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Robb. The network helps show where Sue Robb may publish in the future.
Co-authors
The 21 scholars most cited alongside Sue Robb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 147 | |
| 2 | 1998 | 74 | |
| 3 | 1997 | 70 | |
| 4 | 2015 | 8 | |
| 5 | 1998 | 4 | |
| 6 | 2003 | 2 |
About Sue Robb
Sue Robb is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Oncology, Epidemiology and Education, having authored 6 papers that have together received 305 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (3 papers), Peptidase Inhibition and Analysis (1 paper), Cardiac pacing and defibrillation studies (1 paper), Chronic Disease Management Strategies (1 paper), Atrial Fibrillation Management and Outcomes (1 paper), Hemodynamic Monitoring and Therapy (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper) and Cardiovascular Function and Risk Factors (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (259 citations), Oncology (116 citations), Family Practice (4 citations), Radiology, Nuclear Medicine and Imaging (41 citations) and Cancer Research (18 citations). Sue Robb has collaborated with scholars based in United Kingdom. Frequent co-authors include John J.V. McMurray, David Murdoch, Anna Jones, Andrew Wardley, Peter Barrett‐Lee, Theresa A. McDonagh, Mark Verrill, Peter Canney, Ian Ford and Chris Plummer. Their work appears in journals such as Journal of the American College of Cardiology, British Journal of Cancer, Heart, European Heart Journal and The Journal of Heart and Lung Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.